Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03335540
Title An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb

Advanced Solid Tumor


BMS-986205 + Nivolumab

Nivolumab + Relatlimab

Cabiralizumab + Nivolumab

Lirilumab + Nivolumab

BMS-986156 + Nivolumab

Ipilimumab + Nivolumab


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.